Oaktree Acquisition Corp III Life Sciences (OACC) Income Statement (2024 - 2026)
Income Statement report data from Sep 30, 2024 to Mar 31, 2026 for Oaktree Acquisition Corp III Life Sciences (OACC).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | |
|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||
Selling General And Administrative | 460K (+76.92%) | 260K (+13.04%) | 230K (-14.81%) | 270K (-38.64%) | 440K (+46.67%) | 300K (+500.00%) | 50K |
Operating Expenses | 460K (+76.92%) | 260K (+13.04%) | 230K (-14.81%) | 270K (-38.64%) | 440K (+46.67%) | 300K (+500.00%) | 50K |
Operating Income | |||||||
Operating Income | -460.00K (+76.92%) | -260.00K (+13.04%) | -230.00K (-14.81%) | -270.00K (-38.64%) | -440.00K (+46.67%) | -300.00K (+500.00%) | -50.00K |
EBITDA | -460.00K (+76.92%) | -260.00K (+13.04%) | -230.00K (-14.81%) | -270.00K | 1.66M | -300.00K (+500.00%) | -50.00K |
Other Income / Expenses | |||||||
Interest Income | 1.85M (-9.31%) | 2.04M (-6.85%) | 2.19M (+2.34%) | 2.14M (+1.90%) | 2.10M | - | - |
Net Interest Income | 1.85M (-9.31%) | 2.04M (-6.85%) | 2.19M (+2.34%) | 2.14M (+1.90%) | 2.10M | - | - |
Net Income | |||||||
Income Before Tax | 1.39M (-22.35%) | 1.79M (-9.14%) | 1.97M (+5.35%) | 1.87M (+12.65%) | 1.66M (+20.29%) | 1.38M | -50.00K |
Net Income From Continuing Operations | 1.39M (-22.35%) | 1.79M (-9.14%) | 1.97M (+5.35%) | 1.87M (+12.65%) | 1.66M (+20.29%) | 1.38M | -50.00K |
Net Income | 1.39M (-22.35%) | 1.79M (-9.14%) | 1.97M (+5.35%) | 1.87M (+12.65%) | 1.66M (+20.29%) | 1.38M | -50.00K |